Cholesterol dependence of Newcastle Disease Virus entry.

Departamento de Bioquimica, Universidad de Salamanca, Salamanca, Spain.
Biochimica et Biophysica Acta (Impact Factor: 4.66). 12/2011; 1818(3):753-61. DOI: 10.1016/j.bbamem.2011.12.004
Source: PubMed

ABSTRACT Lipid rafts are membrane microdomains enriched in cholesterol, sphingolipids, and glycolipids that have been implicated in many biological processes. Since cholesterol is known to play a key role in the entry of some other viruses, we investigated the role of cholesterol and lipid rafts in the host cell plasma membrane in Newcastle Disease Virus (NDV) entry. We used methyl-β-cyclodextrin (MβCD) to deplete cellular cholesterol and disrupt lipid rafts. Our results show that the removal of cellular cholesterol partially reduces viral binding, fusion and infectivity. MβCD had no effect on the expression of sialic acid containing molecule expression, the NDV receptors in the target cell. All the above-described effects were reversed by restoring cholesterol levels in the target cell membrane. The HN viral attachment protein partially localized to detergent-resistant membrane microdomains (DRMs) at 4°C and then shifted to detergent-soluble fractions at 37°C. These results indicate that cellular cholesterol may be required for optimal cell entry in NDV infection cycle.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In previous work, we have designed peptides which showed potent inhibition of Newcastle Disease Virus (NDV) and Infectious Bronchitis Virus (IBV) infections in chicken embryos. In this present study, we demonstrate that peptides modified using cholesterol or 3 units of polyethylene glycol (PEG3) conjugated to the peptides' N-terminus presented even more promising antiviral activities when tested in animal models. Both cholesterol and cholesterol-PEG3 tagged peptides were able to protect chicken embryos from infections of different serotypes of NDV and IBV when administered 12 hours prior to virus inoculation. In comparison, un-tagged peptide required intervention closer to the time of viral inoculation to achieve a similar protection. Intramuscular injection of cholesterol-tagged peptide at 1.6 mg/kg one day before virus infection and then once every 3 days for 3 times after viral inoculation protected 70% of the chickens from NDV infection. We further demonstrate that the cholesterol-tagged peptide has an extended in-vivo half-life as compared to un-tagged peptides. It also has the potential to cross the blood-brain barrier to enter the avian central nervous system (CNS). Finally, we show that the cholesterol-tagged peptide could play a role before the viral fusion peptide insertion into the host cell, and thereby target an earlier stage in fusion glycoprotein activation. Our findings are of importance for further development of antivirals with broad-spectrum protective effects.
    Journal of Virology 06/2013; DOI:10.1128/JVI.01153-13 · 4.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Most paramyxoviruses enter the cell by direct fusion of the viral envelope with the plasma membrane. Our previous studies have shown the colocalization of NDV with the early endosome marker EEA1 and the inhibition of NDV fusion by the caveolin-phosphorylating drug PMA prompted us to propose that NDV enters the cells via endocytosis. Here we show that the virus-cell fusion and cell-cell fusion promoted by NDV-F are increased by about 30% after brief exposure to low pH in HeLa and ELL-0 cells but not in NDV receptor-deficient cell lines such as GM95 or Lec1. After a brief low-pH exposure, the percentage of NDV fusion at 29°C was similar to that at 37°C without acid-pH stimulation, meaning that acid pH would decrease the energetic barrier to enhance fusion. Furthermore, preincubation of cells with the PKC inhibitor bisindolylmaleimide led to the inhibition of about 30% of NDV infectivity, suggesting that a population of virus enters cells through receptor-mediated endocytosis. Moreover, the involvement of the GTPase dynamin in NDV entry is shown as its specific inhibitor, dynasore, also impaired NDV fusion and infectivity. Optimal infection of the host cells was significantly affected by drugs that inhibit endosomal acidification such as concanamycin A, monensin and chloroquine. These results support our hypothesis that entry of NDV into ELL-0 and HeLa cells occurs through the plasma membrane as well as by dynamin-, low pH- and receptor-dependent endocytosis.
    Biochimica et Biophysica Acta 08/2013; DOI:10.1016/j.bbamem.2013.08.008 · 4.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastoma multiforme (GBM), or grade IV glioma, is one of the most lethal forms of human brain cancer. Current bioscience has begun to depict more clearly the signalling pathways that are responsible for high-grade glioma initiation, migration, and invasion, opening the door for molecular-based targeted therapy. As such, the application of viruses such as Newcastle disease virus (NDV) as a novel biological bullet to specifically target aberrant signalling in GBM has brought new hope. The abnormal proliferation and aggressive invasion behaviour of GBM is reported to be associated with aberrant Rac1 protein signalling. NDV interacts with Rac1 upon viral entry, syncytium induction, and actin reorganization of the infected cell as part of the replication process. Ultimately, intracellular stress leads the infected glioma cell to undergo cell death. In this review, we describe the characteristics of malignant glioma and the aberrant genetics that drive its aggressive phenotype, and we focus on the use of oncolytic NDV in GBM-targeted therapy and the interaction of NDV in GBM signalling that leads to inhibition of GBM proliferation and invasion, and subsequently, cell death.
    BioMed Research International 08/2014; 2014:386470. DOI:10.1155/2014/386470 · 2.71 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014

Lorena Sanchez